Industry Research Reports
Home > Reports > Medical Devices & Consumables > Global Transcranial Direct Current Stimulation (tDCS) Devices Market Outlook, In‑Depth Analysis & Forecast to 2031
Global Transcranial Direct Current Stimulation (tDCS) Devices Market Outlook, In‑Depth Analysis & Forecast to 2031
Industry: Medical Devices & Consumables
Published Date: 2025-11-02
Pages: 136 Pages
Report ld: 5346325
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Transcranial Direct Current Stimulation (tDCS) Devices Market Size(US$)
CAGR 2025-2031
8.3%
Market Size,2031
USD 324
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 201 million
Market Forecast in 2031(Value)
US$ 324 million
CAGR
8.3%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Transcranial Direct Current Stimulation (tDCS) Devices market is projected to grow from US$ 187 million in 2024 to US$ 324 million by 2031, at a CAGR of 8.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Transcranial electrical stimulation (tES) is a noninvasive brain stimulation technique that passes an electrical current through the cortex of the brain in to alter brain function. The electrical current is applied to an individual’s scalp usually via two or more electrodes, and whilst a large amount of the current is conducted between electrodes through soft tissue and skull,a portion of the current penetrates the scalp and is conducted through the brain, where it can alter neuronal excitability.
Report Includes:
This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Transcranial Direct Current Stimulation (tDCS) Devices market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region's dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- Nexalin Technology
- Interaxon Inc
- ActivaTek
- American Brain
- LIFTiD
- foc.us
- TheBrainDriver
- MDCN TECH
- PlatoScience
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- $100-$200
- $200-$300
- $300-$400
- $400-$500
- ＞$500
Segment by Application
- Home Use
- Medical Institution
- Others
CHAPTER OUTLINE
Chapter 1: Defines the Transcranial Direct Current Stimulation (tDCS) Devices study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; top manufactures 2024 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Transcranial Direct Current Stimulation (tDCS) Devices: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Transcranial Direct Current Stimulation (tDCS) Devices Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 $100-$200
1.2.3 $200-$300
1.2.4 $300-$400
1.2.5 $400-$500
1.2.6 ＞$500
1.3 Market Segmentation by Application
1.3.1 Global Transcranial Direct Current Stimulation (tDCS) Devices Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Home Use
1.3.3 Medical Institution
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Transcranial Direct Current Stimulation (tDCS) Devices Revenue Estimates and Forecasts 2020-2031
2.2 Global Transcranial Direct Current Stimulation (tDCS) Devices Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Transcranial Direct Current Stimulation (tDCS) Devices Sales Estimates and Forecasts 2020-2031
2.4 Global Transcranial Direct Current Stimulation (tDCS) Devices Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Transcranial Direct Current Stimulation (tDCS) Devices Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Transcranial Direct Current Stimulation (tDCS) Devices Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 $100-$200 Market Size by Manufacturers
3.5.2 $200-$300 Market Size by Manufacturers
3.5.3 $300-$400 Market Size by Manufacturers
3.5.4 $400-$500 Market Size by Manufacturers
3.5.5 ＞$500 Market Size by Manufacturers
3.6 Global Transcranial Direct Current Stimulation (tDCS) Devices Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Transcranial Direct Current Stimulation (tDCS) Devices Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Transcranial Direct Current Stimulation (tDCS) Devices Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Transcranial Direct Current Stimulation (tDCS) Devices Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Transcranial Direct Current Stimulation (tDCS) Devices Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Transcranial Direct Current Stimulation (tDCS) Devices Sales and Revenue by Type (2020-2031)
6.4 North America Transcranial Direct Current Stimulation (tDCS) Devices Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Transcranial Direct Current Stimulation (tDCS) Devices Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Transcranial Direct Current Stimulation (tDCS) Devices Sales and Revenue by Type (2020-2031)
7.4 Europe Transcranial Direct Current Stimulation (tDCS) Devices Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Transcranial Direct Current Stimulation (tDCS) Devices Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Transcranial Direct Current Stimulation (tDCS) Devices Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Transcranial Direct Current Stimulation (tDCS) Devices Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Transcranial Direct Current Stimulation (tDCS) Devices Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Transcranial Direct Current Stimulation (tDCS) Devices Sales and Revenue by Type (2020-2031)
9.4 Central and South America Transcranial Direct Current Stimulation (tDCS) Devices Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Transcranial Direct Current Stimulation (tDCS) Devices Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Transcranial Direct Current Stimulation (tDCS) Devices Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Transcranial Direct Current Stimulation (tDCS) Devices Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Transcranial Direct Current Stimulation (tDCS) Devices Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Nexalin Technology
11.1.1 Nexalin Technology Corporation Information
11.1.2 Nexalin Technology Business Overview
11.1.3 Nexalin Technology Transcranial Direct Current Stimulation (tDCS) Devices Product Models, Descriptions and Specifications
11.1.4 Nexalin Technology Transcranial Direct Current Stimulation (tDCS) Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Nexalin Technology Transcranial Direct Current Stimulation (tDCS) Devices Sales by Product in 2024
11.1.6 Nexalin Technology Transcranial Direct Current Stimulation (tDCS) Devices Sales by Application in 2024
11.1.7 Nexalin Technology Transcranial Direct Current Stimulation (tDCS) Devices Sales by Geographic Area in 2024
11.1.8 Nexalin Technology Transcranial Direct Current Stimulation (tDCS) Devices SWOT Analysis
11.1.9 Nexalin Technology Recent Developments
11.2 Interaxon Inc
11.2.1 Interaxon Inc Corporation Information
11.2.2 Interaxon Inc Business Overview
11.2.3 Interaxon Inc Transcranial Direct Current Stimulation (tDCS) Devices Product Models, Descriptions and Specifications
11.2.4 Interaxon Inc Transcranial Direct Current Stimulation (tDCS) Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Interaxon Inc Transcranial Direct Current Stimulation (tDCS) Devices Sales by Product in 2024
11.2.6 Interaxon Inc Transcranial Direct Current Stimulation (tDCS) Devices Sales by Application in 2024
11.2.7 Interaxon Inc Transcranial Direct Current Stimulation (tDCS) Devices Sales by Geographic Area in 2024
11.2.8 Interaxon Inc Transcranial Direct Current Stimulation (tDCS) Devices SWOT Analysis
11.2.9 Interaxon Inc Recent Developments
11.3 ActivaTek
11.3.1 ActivaTek Corporation Information
11.3.2 ActivaTek Business Overview
11.3.3 ActivaTek Transcranial Direct Current Stimulation (tDCS) Devices Product Models, Descriptions and Specifications
11.3.4 ActivaTek Transcranial Direct Current Stimulation (tDCS) Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 ActivaTek Transcranial Direct Current Stimulation (tDCS) Devices Sales by Product in 2024
11.3.6 ActivaTek Transcranial Direct Current Stimulation (tDCS) Devices Sales by Application in 2024
11.3.7 ActivaTek Transcranial Direct Current Stimulation (tDCS) Devices Sales by Geographic Area in 2024
11.3.8 ActivaTek Transcranial Direct Current Stimulation (tDCS) Devices SWOT Analysis
11.3.9 ActivaTek Recent Developments
11.4 American Brain
11.4.1 American Brain Corporation Information
11.4.2 American Brain Business Overview
11.4.3 American Brain Transcranial Direct Current Stimulation (tDCS) Devices Product Models, Descriptions and Specifications
11.4.4 American Brain Transcranial Direct Current Stimulation (tDCS) Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 American Brain Transcranial Direct Current Stimulation (tDCS) Devices Sales by Product in 2024
11.4.6 American Brain Transcranial Direct Current Stimulation (tDCS) Devices Sales by Application in 2024
11.4.7 American Brain Transcranial Direct Current Stimulation (tDCS) Devices Sales by Geographic Area in 2024
11.4.8 American Brain Transcranial Direct Current Stimulation (tDCS) Devices SWOT Analysis
11.4.9 American Brain Recent Developments
11.5 LIFTiD
11.5.1 LIFTiD Corporation Information
11.5.2 LIFTiD Business Overview
11.5.3 LIFTiD Transcranial Direct Current Stimulation (tDCS) Devices Product Models, Descriptions and Specifications
11.5.4 LIFTiD Transcranial Direct Current Stimulation (tDCS) Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 LIFTiD Transcranial Direct Current Stimulation (tDCS) Devices Sales by Product in 2024
11.5.6 LIFTiD Transcranial Direct Current Stimulation (tDCS) Devices Sales by Application in 2024
11.5.7 LIFTiD Transcranial Direct Current Stimulation (tDCS) Devices Sales by Geographic Area in 2024
11.5.8 LIFTiD Transcranial Direct Current Stimulation (tDCS) Devices SWOT Analysis
11.5.9 LIFTiD Recent Developments
11.6 foc.us
11.6.1 foc.us Corporation Information
11.6.2 foc.us Business Overview
11.6.3 foc.us Transcranial Direct Current Stimulation (tDCS) Devices Product Models, Descriptions and Specifications
11.6.4 foc.us Transcranial Direct Current Stimulation (tDCS) Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 foc.us Recent Developments
11.7 TheBrainDriver
11.7.1 TheBrainDriver Corporation Information
11.7.2 TheBrainDriver Business Overview
11.7.3 TheBrainDriver Transcranial Direct Current Stimulation (tDCS) Devices Product Models, Descriptions and Specifications
11.7.4 TheBrainDriver Transcranial Direct Current Stimulation (tDCS) Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 TheBrainDriver Recent Developments
11.8 MDCN TECH
11.8.1 MDCN TECH Corporation Information
11.8.2 MDCN TECH Business Overview
11.8.3 MDCN TECH Transcranial Direct Current Stimulation (tDCS) Devices Product Models, Descriptions and Specifications
11.8.4 MDCN TECH Transcranial Direct Current Stimulation (tDCS) Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 MDCN TECH Recent Developments
11.9 PlatoScience
11.9.1 PlatoScience Corporation Information
11.9.2 PlatoScience Business Overview
11.9.3 PlatoScience Transcranial Direct Current Stimulation (tDCS) Devices Product Models, Descriptions and Specifications
11.9.4 PlatoScience Transcranial Direct Current Stimulation (tDCS) Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 PlatoScience Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Transcranial Direct Current Stimulation (tDCS) Devices Industry Chain
12.2 Transcranial Direct Current Stimulation (tDCS) Devices Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Transcranial Direct Current Stimulation (tDCS) Devices Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Transcranial Direct Current Stimulation (tDCS) Devices Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Transcranial Direct Current Stimulation (tDCS) Devices Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Transcranial Direct Current Stimulation (tDCS) Devices Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Transcranial Direct Current Stimulation (tDCS) Devices Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Transcranial Direct Current Stimulation (tDCS) Devices Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Transcranial Direct Current Stimulation (tDCS) Devices Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Transcranial Direct Current Stimulation (tDCS) Devices Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Transcranial Direct Current Stimulation (tDCS) Devices Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Transcranial Direct Current Stimulation (tDCS) Devices Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
Table 7. Global Transcranial Direct Current Stimulation (tDCS) Devices Sales by Region (2020-2025) & (K Units)
Table 8. Global Transcranial Direct Current Stimulation (tDCS) Devices Sales by Region (2026-2031) & (K Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Transcranial Direct Current Stimulation (tDCS) Devices Sales by Manufacturers (2020-2025) & (K Units)
Table 11. Global Transcranial Direct Current Stimulation (tDCS) Devices Sales Share by Manufacturers (2020-2025)
Table 12. Global Transcranial Direct Current Stimulation (tDCS) Devices Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Transcranial Direct Current Stimulation (tDCS) Devices Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Transcranial Direct Current Stimulation (tDCS) Devices by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transcranial Direct Current Stimulation (tDCS) Devices as of 2024)
Table 16. Global Transcranial Direct Current Stimulation (tDCS) Devices Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Transcranial Direct Current Stimulation (tDCS) Devices Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 18. Key Manufacturers Transcranial Direct Current Stimulation (tDCS) Devices Manufacturing Base and Headquarters
Table 19. Global Transcranial Direct Current Stimulation (tDCS) Devices Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Transcranial Direct Current Stimulation (tDCS) Devices Sales by Type (2020-2025) & (K Units)
Table 23. Global Transcranial Direct Current Stimulation (tDCS) Devices Sales by Type (2026-2031) & (K Units)
Table 24. Global Transcranial Direct Current Stimulation (tDCS) Devices Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Transcranial Direct Current Stimulation (tDCS) Devices Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Transcranial Direct Current Stimulation (tDCS) Devices ASP by Type (2020-2031) & (US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Transcranial Direct Current Stimulation (tDCS) Devices Sales by Application (2020-2025) & (K Units)
Table 29. Global Transcranial Direct Current Stimulation (tDCS) Devices Sales by Application (2026-2031) & (K Units)
Table 30. Transcranial Direct Current Stimulation (tDCS) Devices High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Transcranial Direct Current Stimulation (tDCS) Devices Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Transcranial Direct Current Stimulation (tDCS) Devices Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Transcranial Direct Current Stimulation (tDCS) Devices ASP by Application (2020-2031) & (US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Transcranial Direct Current Stimulation (tDCS) Devices Growth Accelerators and Market Barriers
Table 37. North America Transcranial Direct Current Stimulation (tDCS) Devices Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Transcranial Direct Current Stimulation (tDCS) Devices Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Transcranial Direct Current Stimulation (tDCS) Devices Growth Accelerators and Market Barriers
Table 40. Europe Transcranial Direct Current Stimulation (tDCS) Devices Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Transcranial Direct Current Stimulation (tDCS) Devices Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Transcranial Direct Current Stimulation (tDCS) Devices Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Transcranial Direct Current Stimulation (tDCS) Devices Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Transcranial Direct Current Stimulation (tDCS) Devices Growth Accelerators and Market Barriers
Table 45. Southeast Asia Transcranial Direct Current Stimulation (tDCS) Devices Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Transcranial Direct Current Stimulation (tDCS) Devices Investment Opportunities and Key Challenges
Table 47. Central and South America Transcranial Direct Current Stimulation (tDCS) Devices Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Transcranial Direct Current Stimulation (tDCS) Devices Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Transcranial Direct Current Stimulation (tDCS) Devices Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Nexalin Technology Corporation Information
Table 51. Nexalin Technology Description and Major Businesses
Table 52. Nexalin Technology Product Models, Descriptions and Specifications
Table 53. Nexalin Technology Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 54. Nexalin Technology Sales Value Proportion by Product in 2024
Table 55. Nexalin Technology Sales Value Proportion by Application in 2024
Table 56. Nexalin Technology Sales Value Proportion by Geographic Area in 2024
Table 57. Nexalin Technology Transcranial Direct Current Stimulation (tDCS) Devices SWOT Analysis
Table 58. Nexalin Technology Recent Developments
Table 59. Interaxon Inc Corporation Information
Table 60. Interaxon Inc Description and Major Businesses
Table 61. Interaxon Inc Product Models, Descriptions and Specifications
Table 62. Interaxon Inc Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 63. Interaxon Inc Sales Value Proportion by Product in 2024
Table 64. Interaxon Inc Sales Value Proportion by Application in 2024
Table 65. Interaxon Inc Sales Value Proportion by Geographic Area in 2024
Table 66. Interaxon Inc Transcranial Direct Current Stimulation (tDCS) Devices SWOT Analysis
Table 67. Interaxon Inc Recent Developments
Table 68. ActivaTek Corporation Information
Table 69. ActivaTek Description and Major Businesses
Table 70. ActivaTek Product Models, Descriptions and Specifications
Table 71. ActivaTek Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. ActivaTek Sales Value Proportion by Product in 2024
Table 73. ActivaTek Sales Value Proportion by Application in 2024
Table 74. ActivaTek Sales Value Proportion by Geographic Area in 2024
Table 75. ActivaTek Transcranial Direct Current Stimulation (tDCS) Devices SWOT Analysis
Table 76. ActivaTek Recent Developments
Table 77. American Brain Corporation Information
Table 78. American Brain Description and Major Businesses
Table 79. American Brain Product Models, Descriptions and Specifications
Table 80. American Brain Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. American Brain Sales Value Proportion by Product in 2024
Table 82. American Brain Sales Value Proportion by Application in 2024
Table 83. American Brain Sales Value Proportion by Geographic Area in 2024
Table 84. American Brain Transcranial Direct Current Stimulation (tDCS) Devices SWOT Analysis
Table 85. American Brain Recent Developments
Table 86. LIFTiD Corporation Information
Table 87. LIFTiD Description and Major Businesses
Table 88. LIFTiD Product Models, Descriptions and Specifications
Table 89. LIFTiD Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. LIFTiD Sales Value Proportion by Product in 2024
Table 91. LIFTiD Sales Value Proportion by Application in 2024
Table 92. LIFTiD Sales Value Proportion by Geographic Area in 2024
Table 93. LIFTiD Transcranial Direct Current Stimulation (tDCS) Devices SWOT Analysis
Table 94. LIFTiD Recent Developments
Table 95. foc.us Corporation Information
Table 96. foc.us Description and Major Businesses
Table 97. foc.us Product Models, Descriptions and Specifications
Table 98. foc.us Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. foc.us Recent Developments
Table 100. TheBrainDriver Corporation Information
Table 101. TheBrainDriver Description and Major Businesses
Table 102. TheBrainDriver Product Models, Descriptions and Specifications
Table 103. TheBrainDriver Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. TheBrainDriver Recent Developments
Table 105. MDCN TECH Corporation Information
Table 106. MDCN TECH Description and Major Businesses
Table 107. MDCN TECH Product Models, Descriptions and Specifications
Table 108. MDCN TECH Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 109. MDCN TECH Recent Developments
Table 110. PlatoScience Corporation Information
Table 111. PlatoScience Description and Major Businesses
Table 112. PlatoScience Product Models, Descriptions and Specifications
Table 113. PlatoScience Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 114. PlatoScience Recent Developments
Table 115. Key Raw Materials Distribution
Table 116. Raw Materials Key Suppliers
Table 117. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 118. Milestones in Production Technology Evolution
Table 119. Distributors List
Table 120. Market Trends and Market Evolution
Table 121. Market Drivers and Opportunities
Table 122. Market Challenges, Risks, and Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Transcranial Direct Current Stimulation (tDCS) Devices Product Picture
Figure 2. Global Transcranial Direct Current Stimulation (tDCS) Devices Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. $100-$200 Product Picture
Figure 4. $200-$300 Product Picture
Figure 5. $300-$400 Product Picture
Figure 6. $400-$500 Product Picture
Figure 7. ＞$500 Product Picture
Figure 8. Global Transcranial Direct Current Stimulation (tDCS) Devices Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 9. Home Use
Figure 10. Medical Institution
Figure 11. Others
Figure 12. Transcranial Direct Current Stimulation (tDCS) Devices Report Years Considered
Figure 13. Global Transcranial Direct Current Stimulation (tDCS) Devices Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Transcranial Direct Current Stimulation (tDCS) Devices Revenue (2020-2031) & (US$ Million)
Figure 15. Global Transcranial Direct Current Stimulation (tDCS) Devices Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 16. Global Transcranial Direct Current Stimulation (tDCS) Devices Revenue Market Share by Region (2020-2031)
Figure 17. Global Transcranial Direct Current Stimulation (tDCS) Devices Sales (2020-2031) & (K Units)
Figure 18. Global Transcranial Direct Current Stimulation (tDCS) Devices Sales (CAGR) by Region (2020-2031) (K Units)
Figure 19. Global Transcranial Direct Current Stimulation (tDCS) Devices Sales Market Share by Region (2020-2031)
Figure 20. Top 5 and Top 10 Manufacturers Transcranial Direct Current Stimulation (tDCS) Devices Sales Volume Market Share in 2024
Figure 21. Global Transcranial Direct Current Stimulation (tDCS) Devices Revenue Market Share Ranking (2024)
Figure 22. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 23. $100-$200 Revenue Market Share by Manufacturer in 2024
Figure 24. $200-$300 Revenue Market Share by Manufacturer in 2024
Figure 25. $300-$400 Revenue Market Share by Manufacturer in 2024
Figure 26. $400-$500 Revenue Market Share by Manufacturer in 2024
Figure 27. ＞$500 Revenue Market Share by Manufacturer in 2024
Figure 28. Global Transcranial Direct Current Stimulation (tDCS) Devices Sales Market Share by Type (2020-2031)
Figure 29. Global Transcranial Direct Current Stimulation (tDCS) Devices Revenue Market Share by Type (2020-2031)
Figure 30. Global Transcranial Direct Current Stimulation (tDCS) Devices Sales Market Share by Application (2020-2031)
Figure 31. Global Transcranial Direct Current Stimulation (tDCS) Devices Revenue Market Share by Application (2020-2031)
Figure 32. North America Transcranial Direct Current Stimulation (tDCS) Devices Sales YoY (2020-2031) & (K Units)
Figure 33. North America Transcranial Direct Current Stimulation (tDCS) Devices Revenue YoY (2020-2031) & (US$ Million)
Figure 34. North America Top 5 Manufacturers Transcranial Direct Current Stimulation (tDCS) Devices Sales Revenue (US$ Million) in 2024
Figure 35. North America Transcranial Direct Current Stimulation (tDCS) Devices Sales Volume (K Units) by Type (2020- 2031)
Figure 36. North America Transcranial Direct Current Stimulation (tDCS) Devices Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 37. North America Transcranial Direct Current Stimulation (tDCS) Devices Sales Volume (K Units) by Application (2020-2031)
Figure 38. North America Transcranial Direct Current Stimulation (tDCS) Devices Sales Revenue (US$ Million) by Application (2020-2031)
Figure 39. US Transcranial Direct Current Stimulation (tDCS) Devices Revenue (2020-2031) & (US$ Million)
Figure 40. Canada Transcranial Direct Current Stimulation (tDCS) Devices Revenue (2020-2031) & (US$ Million)
Figure 41. Mexico Transcranial Direct Current Stimulation (tDCS) Devices Revenue (2020-2031) & (US$ Million)
Figure 42. Europe Transcranial Direct Current Stimulation (tDCS) Devices Sales YoY (2020-2031) & (K Units)
Figure 43. Europe Transcranial Direct Current Stimulation (tDCS) Devices Revenue YoY (2020-2031) & (US$ Million)
Figure 44. Europe Top 5 Manufacturers Transcranial Direct Current Stimulation (tDCS) Devices Sales Revenue (US$ Million) in 2024
Figure 45. Europe Transcranial Direct Current Stimulation (tDCS) Devices Sales Volume (K Units) by Type (2020-2031)
Figure 46. Europe Transcranial Direct Current Stimulation (tDCS) Devices Sales Revenue (US$ Million) by Type (2020-2031)
Figure 47. Europe Transcranial Direct Current Stimulation (tDCS) Devices Sales Volume (K Units) by Application (2020-2031)
Figure 48. Europe Transcranial Direct Current Stimulation (tDCS) Devices Sales Revenue (US$ Million) by Application (2020-2031)
Figure 49. Germany Transcranial Direct Current Stimulation (tDCS) Devices Revenue (2020-2031) & (US$ Million)
Figure 50. France Transcranial Direct Current Stimulation (tDCS) Devices Revenue (2020-2031) & (US$ Million)
Figure 51. U.K. Transcranial Direct Current Stimulation (tDCS) Devices Revenue (2020-2031) & (US$ Million)
Figure 52. Italy Transcranial Direct Current Stimulation (tDCS) Devices Revenue (2020-2031) & (US$ Million)
Figure 53. Russia Transcranial Direct Current Stimulation (tDCS) Devices Revenue (2020-2031) & (US$ Million)
Figure 54. Asia-Pacific Transcranial Direct Current Stimulation (tDCS) Devices Sales YoY (2020-2031) & (K Units)
Figure 55. Asia-Pacific Transcranial Direct Current Stimulation (tDCS) Devices Revenue YoY (2020-2031) & (US$ Million)
Figure 56. Asia-Pacific Top 8 Manufacturers Transcranial Direct Current Stimulation (tDCS) Devices Sales Revenue (US$ Million) in 2024
Figure 57. Asia-Pacific Transcranial Direct Current Stimulation (tDCS) Devices Sales Volume (K Units) by Type (2020- 2031)
Figure 58. Asia-Pacific Transcranial Direct Current Stimulation (tDCS) Devices Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 59. Asia-Pacific Transcranial Direct Current Stimulation (tDCS) Devices Sales Volume (K Units) by Application (2020-2031)
Figure 60. Asia-Pacific Transcranial Direct Current Stimulation (tDCS) Devices Sales Revenue (US$ Million) by Application (2020-2031)
Figure 61. Indonesia Transcranial Direct Current Stimulation (tDCS) Devices Revenue (2020-2031) & (US$ Million)
Figure 62. Japan Transcranial Direct Current Stimulation (tDCS) Devices Revenue (2020-2031) & (US$ Million)
Figure 63. South Korea Transcranial Direct Current Stimulation (tDCS) Devices Revenue (2020-2031) & (US$ Million)
Figure 64. China Taiwan Transcranial Direct Current Stimulation (tDCS) Devices Revenue (2020-2031) & (US$ Million)
Figure 65. India Transcranial Direct Current Stimulation (tDCS) Devices Revenue (2020-2031) & (US$ Million)
Figure 66. Central and South America Transcranial Direct Current Stimulation (tDCS) Devices Sales YoY (2020-2031) & (K Units)
Figure 67. Central and South America Transcranial Direct Current Stimulation (tDCS) Devices Revenue YoY (2020-2031) & (US$ Million)
Figure 68. Central and South America Top 5 Manufacturers Transcranial Direct Current Stimulation (tDCS) Devices Sales Revenue (US$ Million) in 2024
Figure 69. Central and South America Transcranial Direct Current Stimulation (tDCS) Devices Sales Volume (K Units) by Type (2021-2031)
Figure 70. Central and South America Transcranial Direct Current Stimulation (tDCS) Devices Sales Revenue (US$ Million) by Type (2020-2031)
Figure 71. Central and South America Transcranial Direct Current Stimulation (tDCS) Devices Sales Volume (K Units) by Application (2020-2031)
Figure 72. Central and South America Transcranial Direct Current Stimulation (tDCS) Devices Sales Revenue (US$ Million) by Application (2020-2031)
Figure 73. Brazil Transcranial Direct Current Stimulation (tDCS) Devices Revenue (2020-2025) & (US$ Million)
Figure 74. Argentina Transcranial Direct Current Stimulation (tDCS) Devices Revenue (2020-2025) & (US$ Million)
Figure 75. Middle East, and Africa Transcranial Direct Current Stimulation (tDCS) Devices Sales YoY (2020-2031) & (K Units)
Figure 76. Middle East and Africa Transcranial Direct Current Stimulation (tDCS) Devices Revenue YoY (2020-2031) & (US$ Million)
Figure 77. Middle East and Africa Top 5 Manufacturers Transcranial Direct Current Stimulation (tDCS) Devices Sales Revenue (US$ Million) in 2024
Figure 78. Middle East and Africa Transcranial Direct Current Stimulation (tDCS) Devices Sales Volume (K Units) by Type (2021-2031)
Figure 79. South America Transcranial Direct Current Stimulation (tDCS) Devices Sales Revenue (US$ Million) by Type (2020-2031)
Figure 80. Middle East and Africa Transcranial Direct Current Stimulation (tDCS) Devices Sales Volume (K Units) by Application (2020-2031)
Figure 81. Middle East and Africa Transcranial Direct Current Stimulation (tDCS) Devices Sales Revenue (US$ Million) by Application (2020-2031)
Figure 82. GCC Countries Transcranial Direct Current Stimulation (tDCS) Devices Revenue (2020-2025) & (US$ Million)
Figure 83. Turkey Transcranial Direct Current Stimulation (tDCS) Devices Revenue (2020-2025) & (US$ Million)
Figure 84. Egypt Transcranial Direct Current Stimulation (tDCS) Devices Revenue (2020-2025) & (US$ Million)
Figure 85. South Africa Transcranial Direct Current Stimulation (tDCS) Devices Revenue (2020-2025) & (US$ Million)
Figure 86. Transcranial Direct Current Stimulation (tDCS) Devices Industry Chain Mapping
Figure 87. Regional Transcranial Direct Current Stimulation (tDCS) Devices Manufacturing Base Distribution (%)
Figure 88. Global Transcranial Direct Current Stimulation (tDCS) Devices Production Market Share by Region (2020-2031)
Figure 89. Transcranial Direct Current Stimulation (tDCS) Devices Production Process
Figure 90. Regional Transcranial Direct Current Stimulation (tDCS) Devices Production Cost Structure
Figure 91. Channels of Distribution (Direct Vs Distribution)
Figure 92. Bottom-up and Top-down Approaches for This Report
Figure 93. Data Triangulation
Figure 94. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What was the global market size of Transcranial Direct Current Stimulation (tDCS) Devices in 2025?
The global market size of Transcranial Direct Current Stimulation (tDCS) Devices in 2025 was 201 Million USD.
What is the annual compound growth rate of the global Transcranial Direct Current Stimulation (tDCS) Devices market size from 2025 to 2031?
What was the global market size of Transcranial Direct Current Stimulation (tDCS) Devices in 2031?
Which region is expected to have the highest market share?
Which companies rank high in the global Transcranial Direct Current Stimulation (tDCS) Devices market?
Related Reports
Transcranial Direct Current Stimulation (tDCS) Devices- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Transcranial Direct Current Stimulation (tDCS) Devices was estimated to be worth US$ 201 million in 2025 and is projected to reach US$ 348 million, growing at a CAGR of 8.3% from 2026 to 2032.
Published Date: 2026-06-16
Pages: 130
USD 3950.00
(Single User License)
Global Transcranial Direct Current Stimulation (tDCS) Devices Market Research Report 2026
The global Transcranial Direct Current Stimulation (tDCS) Devices market was valued at US$ 201 million in 2025 and is anticipated to reach US$ 348 million by 2032, at a CAGR of 8.3% from 2026 to 2032.
Published Date: 2026-04-17
Pages: 117
USD 2900.00
(Single User License)
Global Transcranial Direct Current Stimulation (tDCS) Devices Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Transcranial Direct Current Stimulation (tDCS) Devices market size was US$ 187 million in 2024 and is forecast to a readjusted size of US$ 324 million by 2031 with a CAGR of 8.3% during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 79
USD 4250.00
(Single User License)
Transcranial Direct Current Stimulation (tDCS) Devices- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Transcranial Direct Current Stimulation (tDCS) Devices was estimated to be worth US$ 187 million in 2024 and is forecast to a readjusted size of US$ 324 million by 2031 with a CAGR of 8.3% during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 105
USD 3950.00
(Single User License)
Global Transcranial Direct Current Stimulation (tDCS) Devices Market Research Report 2025
The global market for Transcranial Direct Current Stimulation (tDCS) Devices was valued at US$ 187 million in the year 2024 and is projected to reach a revised size of US$ 324 million by 2031, growing at a CAGR of 8.3% during the forecast period.
Published Date: 2025-01-13
Pages: 84
USD 2900.00
(Single User License)
Global Transcranial Direct Current Stimulation (tDCS) Devices Market Insights, Forecast to 2030
The global Transcranial Direct Current Stimulation (tDCS) Devices market is projected to grow from US$ 174 million in 2024 to US$ 280.8 million by 2030, at a Compound Annual Growth Rate (CAGR) of 8.3% during the forecast period.
Published Date: 2024-04-26
Pages: 97
USD 4900.00
(Single User License)
Global Transcranial Direct Current Stimulation (tDCS) Devices Market Research Report 2024
The global Transcranial Direct Current Stimulation (tDCS) Devices market was valued at US$ 160 million in 2023 and is anticipated to reach US$ 280.8 million by 2030, witnessing a CAGR of 8.3% during the forecast period 2024-2030.
Published Date: 2024-01-18
Pages: 81
USD 2900.00
(Single User License)
Transcranial Direct Current Stimulation (tDCS) Devices- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Transcranial Direct Current Stimulation (tDCS) Devices was estimated to be worth US$ 201 million in 2025 and is projected to reach US$ 348 million, growing at a CAGR of 8.3% from 2026 to 2032.
Published: 2026-06-16
Pages: 130
USD 3950.00 (Single User License)Global Transcranial Direct Current Stimulation (tDCS) Devices Market Research Report 2026
The global Transcranial Direct Current Stimulation (tDCS) Devices market was valued at US$ 201 million in 2025 and is anticipated to reach US$ 348 million by 2032, at a CAGR of 8.3% from 2026 to 2032.
Published: 2026-04-17
Pages: 117
USD 2900.00 (Single User License)Global Transcranial Direct Current Stimulation (tDCS) Devices Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Transcranial Direct Current Stimulation (tDCS) Devices market size was US$ 187 million in 2024 and is forecast to a readjusted size of US$ 324 million by 2031 with a CAGR of 8.3% during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 79
USD 4250.00 (Single User License)Transcranial Direct Current Stimulation (tDCS) Devices- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Transcranial Direct Current Stimulation (tDCS) Devices was estimated to be worth US$ 187 million in 2024 and is forecast to a readjusted size of US$ 324 million by 2031 with a CAGR of 8.3% during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 105
USD 3950.00 (Single User License)Global Transcranial Direct Current Stimulation (tDCS) Devices Market Research Report 2025
The global market for Transcranial Direct Current Stimulation (tDCS) Devices was valued at US$ 187 million in the year 2024 and is projected to reach a revised size of US$ 324 million by 2031, growing at a CAGR of 8.3% during the forecast period.
Published: 2025-01-13
Pages: 84
USD 2900.00 (Single User License)Global Transcranial Direct Current Stimulation (tDCS) Devices Market Insights, Forecast to 2030
The global Transcranial Direct Current Stimulation (tDCS) Devices market is projected to grow from US$ 174 million in 2024 to US$ 280.8 million by 2030, at a Compound Annual Growth Rate (CAGR) of 8.3% during the forecast period.
Published: 2024-04-26
Pages: 97
USD 4900.00 (Single User License)Global Transcranial Direct Current Stimulation (tDCS) Devices Market Research Report 2024
The global Transcranial Direct Current Stimulation (tDCS) Devices market was valued at US$ 160 million in 2023 and is anticipated to reach US$ 280.8 million by 2030, witnessing a CAGR of 8.3% during the forecast period 2024-2030.
Published: 2024-01-18
Pages: 81
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now